Abstract
Inflammatory Bowel Diseases (IBD), such as Crohn's disease and ulcerative colitis, are chronic and debilitating conditions that affect millions of people worldwide, significantly impacting quality of life and public health. The increasing prevalence of these diseases poses a major challenge and is associated with imbalances in the gut microbiota (dysbiosis) and epigenetic modifications, s…